CV Sciences, Inc. (OTCMKTS:CVSI) Short Interest Down 82.5% in January

CV Sciences, Inc. (OTCMKTS:CVSI) saw a large decline in short interest in the month of January. As of January 15th, there was short interest totalling 6,400 shares, a decline of 82.5% from the December 31st total of 36,600 shares. Based on an average daily trading volume, of 697,100 shares, the days-to-cover ratio is currently 0.0 days.

CV Sciences Price Performance

OTCMKTS:CVSI traded up $0.00 during trading hours on Wednesday, reaching $0.04. 15,268 shares of the company were exchanged, compared to its average volume of 256,152. The firm has a market cap of $7.48 million, a price-to-earnings ratio of -4.05 and a beta of 0.66. The stock has a 50 day simple moving average of $0.04 and a 200 day simple moving average of $0.04. CV Sciences has a 52-week low of $0.03 and a 52-week high of $0.10.

About CV Sciences

CV Sciences, Inc develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers.